NCT07779044

Brief Summary

This randomized controlled trial evaluated the effectiveness of a mindfulness-based cognitive behavioral program in improving quality of life and glycemic control among adults with diabetes mellitus in Damascus, Syria. The intervention combined cognitive behavioral strategies and mindfulness practices and was delivered through 14 weekly sessions over approximately three months. Quality of life was assessed using the WHOQOL-BREF, and glycemic control was assessed using glycated hemoglobin (HbA1c) levels. The study compared participants receiving the intervention with a control group receiving routine diabetes care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 26, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

August 17, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 17, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

Diabetes mellitusMindfulnessCognitive Behavioral TherapyQuality of LifeGlycated HemoglobinRandomized Controlled Trial.Depression

Outcome Measures

Primary Outcomes (1)

  • Change in Glycated Hemoglobin (HbA1c) Level

    Change in HbA1c level from baseline to immediately after completion of the intervention.

    Baseline and 3 months (post-intervention).

Secondary Outcomes (1)

  • Within-group change in Quality of Life Measured by the World Health Organization Quality of Life-BREF (WHOQOL-BREF) Questionnaire

    Baseline and 3 months (evaluated in the intervention arm).

Study Arms (2)

Mindfulness-Based Cognitive Behavioral Intervention

EXPERIMENTAL

Participants received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions over approximately three months, in addition to routine diabetes care.

Behavioral: Mindfulness-Based Cognitive Behavioral Program

Routine Diabetes Care (Control)

NO INTERVENTION

Participants received routine diabetes care without any additional psychological or behavioral intervention during the study period.

Interventions

Participants in the intervention group received a structured mindfulness-based cognitive behavioral program consisting of 14 weekly sessions delivered over approximately three months. Each session lasted approximately 90 minutes, including a 15-minute break. The program incorporated psychoeducation, cognitive restructuring, mindfulness exercises, behavioral activation, emotional regulation, relaxation techniques, coping strategies, and home practice assignments. The intervention was delivered by qualified mental health professionals in addition to routine diabetes care.

Mindfulness-Based Cognitive Behavioral Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-70 years.
  • Diagnosis of type 1 or type 2 diabetes mellitus.
  • Baseline HbA1c level greater than 6.5%.
  • Mild to moderate depressive symptoms according to the Beck Depression - -Inventory (BDI).
  • Ability to understand the study procedures and intervention instructions.
  • Willingness to participate in all intervention sessions.
  • Ability and willingness to provide written informed consent.

You may not qualify if:

  • Severe psychiatric disorders requiring specialized psychiatric care.
  • Acute medical conditions that could prevent participation in the intervention.
  • Receiving regular psychotherapy or another similar psychological intervention.
  • Inability to understand the intervention instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Strategic Studies and Health Training

Damascus, Damascus Governorate, Syria

Location

Related Publications (6)

  • Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR, Ismail K. Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2020 Apr;8(1):e001150. doi: 10.1136/bmjdrc-2019-001150.

  • Newby J, Robins L, Wilhelm K, Smith J, Fletcher T, Gillis I, Ma T, Finch A, Campbell L, Andrews G. Web-Based Cognitive Behavior Therapy for Depression in People With Diabetes Mellitus: A Randomized Controlled Trial. J Med Internet Res. 2017 May 15;19(5):e157. doi: 10.2196/jmir.7274.

  • Zarifsanaiey N, Jamalian K, Bazrafcan L, Keshavarzy F, Shahraki HR. The effects of mindfulness training on the level of happiness and blood sugar in diabetes patients. J Diabetes Metab Disord. 2020 Mar 2;19(1):311-317. doi: 10.1007/s40200-020-00510-7. eCollection 2020 Jun.

  • Yang X, Li Z, Sun J. Effects of Cognitive Behavioral Therapy-Based Intervention on Improving Glycaemic, Psychological, and Physiological Outcomes in Adult Patients With Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. Front Psychiatry. 2020 Jul 28;11:711. doi: 10.3389/fpsyt.2020.00711. eCollection 2020.

  • Ni YX, Ma L, Li JP. Effects of mindfulness-based intervention on glycemic control and psychological outcomes in people with diabetes: A systematic review and meta-analysis. J Diabetes Investig. 2021 Jun;12(6):1092-1103. doi: 10.1111/jdi.13439. Epub 2020 Nov 22.

  • DiNardo MM, Greco C, Phares AD, Beyer NM, Youk AO, Obrosky DS, Morone NE, Owen JE, Saba SK, Suss SJ, Siminerio L. Effects of an integrated mindfulness intervention for veterans with diabetes distress: a randomized controlled trial. BMJ Open Diabetes Res Care. 2022 Mar;10(2):e002631. doi: 10.1136/bmjdrc-2021-002631.

MeSH Terms

Conditions

Diabetes MellitusDepression

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavioral SymptomsBehavior

Study Officials

  • ZaynALsham M AlQatrangi, BPharm, MPH

    Center for Strategic Studies and Health Training

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned to either an intervention group receiving a mindfulness-based cognitive behavioral program or a control group receiving routine diabetes care. Participants remained in their assigned groups throughout the study, with assessments conducted before and after the intervention.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2026

First Posted

August 21, 2026

Study Start

October 26, 2025

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

August 27, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers because of privacy and confidentiality considerations and to protect the personal and health information of study participants.

Locations